image credit: Pexels

WHO: More than 70 COVID-19 Vaccines are in Development, Three in Clinical Trials

More than 2 million people have been diagnosed with COVID-19, and the pharmaceutical industry is pulling out all stops to find potential treatments and vaccines for the global pandemic. According to the World Health Organization (WHO), there are now more than 70 potential vaccines under development, with three already in clinical trials.

The most advanced clinical trial is CanSino’s Adenovirus Type 5 Vector, Ad5-nCoV, which has been moved into Phase II. Ad5-nCoV is a genetic engineered vaccine candidate with the replication-defective adenovirus type 5 as the vector to express SARS-CoV-2 spike protein, which intends to be used to prevent the disease caused by the novel coronavirus infection, the company said in its filing.

Read More on BioSpace